Company / Operating Income per Share
NovaBay Pharmaceuticals, Inc. Operating Income per Share History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$1.20
FY2024
5-year range
-$7.08 / -$0.18
FY2020-FY2024
Trend
-227.2%
vs FY2023
Sector context
#91 of 199
Health Care
What the data says
Operating Income per Share changed -227% YoY in FY2024, a notable deviation from the 9-year average annual change of -368%.
Based on SEC 10-K filings.
-1.20 in FY2024.
Improved from $-7.08 to $-1.20 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#91 of 199 in Health CareTop 46% of 199This company -$1.20 Sector average -$3.34
▼
+64.2% above sector average
Key checks
Key Insights
- In FY2024, operating income per share decreased 227.2% year-over-year.
- Ranks #91 out of 199 companies in the Health Care sector.
- Peak operating income per share was recorded in FY2020.
- Lowest operating income per share in the period was in FY2015.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -5.51 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$1.20 | -227.2% |
| FY2023 | -$0.37 | +94.8% |
| FY2022 | -$7.08 | -3390.1% |
| FY2021 | -$0.20 | -10.8% |
| FY2020 | -$0.18 | +57.8% |
| FY2019 | -$0.43 | +5.9% |
| FY2018 | -$0.46 | +3.6% |
| FY2017 | -$0.48 | +84.8% |
| FY2016 | -$3.15 | +69.2% |
| FY2015 | -$10.23 | -2600.8% |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026